PNC FINANCIAL SERVICES GROUP, INC. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,060,491
-2.8%
327,116
-1.3%
0.00%0.0%
Q2 2023$5,204,152
-9.4%
331,264
-5.0%
0.00%
-20.0%
Q1 2023$5,745,517
+3.5%
348,636
-2.0%
0.01%0.0%
Q4 2022$5,549,242
+16.7%
355,721
-2.9%
0.01%0.0%
Q3 2022$4,755,000
-0.2%
366,507
+8.0%
0.01%0.0%
Q2 2022$4,763,000
-10.5%
339,221
-8.7%
0.01%0.0%
Q1 2022$5,319,000
-2.8%
371,396
-7.5%
0.01%0.0%
Q4 2021$5,475,000
-25.7%
401,711
-10.8%
0.01%
-28.6%
Q3 2021$7,373,000
-2.3%
450,114
+0.4%
0.01%0.0%
Q2 2021$7,543,000
-5.5%
448,146
+2.5%
0.01%
-12.5%
Q1 2021$7,985,000
-0.9%
437,259
-1.2%
0.01%0.0%
Q4 2020$8,057,000
+1.9%
442,711
-0.1%
0.01%
-20.0%
Q3 2020$7,907,000
-6.6%
443,150
-6.2%
0.01%
-9.1%
Q2 2020$8,470,000
+0.9%
472,308
-14.6%
0.01%0.0%
Q1 2020$8,397,000
-25.9%
553,176
-3.7%
0.01%0.0%
Q4 2019$11,329,000
+15.1%
574,260
+0.3%
0.01%
+10.0%
Q3 2019$9,843,000
-8.2%
572,311
-5.6%
0.01%
-9.1%
Q2 2019$10,727,000
-13.9%
606,036
-0.9%
0.01%
-8.3%
Q1 2019$12,453,000
+154.7%
611,355
+110.3%
0.01%
+140.0%
Q4 2018$4,889,000
+69742.9%
290,705
+91316.7%
0.01%
Q4 2014$7,0003180.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders